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delivered twice a week with a VMAT technique, with 2 arcs 
using 6MV photons from a Varian iX linac. Planning was 
performed by 3 different planners in Varian Eclipse 10.0 TPS 
with the AAA algorithm. Dose prescription is the average dose 
to PTV, with the request V95% >95%. Plan quality was 
assessed using van’t Riet dose conformation number (CN95%), 
Baltas conformity index (COIN), ICRU-83 homogeneity index 
(HI), the ratio of the 50% isodose volume to PTV (R50%) to 
assess intermediate dose spillage, and compliance to protocol 
constraints. Correlation between each quality index and 
protocol compliance was performed to identify the most 
efficient ones. 
Results: The main dosimetric results are presented in the 
following table. For the PTV only the constraint for D98% is not 
met in 2 cases. As for the OARs, most dosimetric parameters 
are well within the protocol constraints, with the notable 
exception of maximal doses to rectum and bladder (D1% less 
than 95% and 100% of the prescription dose, respectively) for 
which the constraints are exceeded in about 20% of cases. 
Mean and s.d. values for CN95%, COIN, R50%, HI are 
0.90±0.05, 0.86±0.05, 3.4±0.3, 9.9%±2.2%, respectively. CN95% 
results moreover linearly correlated with both COIN and 
R50%. It increases with HI and seems to reach a plateau for HI 
about 11% (see Figure). 
 
 
 
Conclusions: Analysis has shown good coverage of PTV and 
difficulty to meet the constraints relative to the maximal 
doses of rectum and bladder when these are significantly 
included in the PTV. As for the measure of plan quality, the 
average value of CN95% is well above the 0.80 threshold, while 
its small coefficient of variation suggests a consistent 
application of the planning protocol among the different 
planners involved in the study. Due to its correlation with 
COIN and R50%, CN95% seems the most effective quantitative 
measure for plan quality in terms of target coverage, dose 
fall-off and/or general normal tissue sparing. Finally, the 
best conformity is obtained only with a given degree of dose 
inhomogeneity in the PTV.  
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Purpose/Objective: Stereotactic Ablative Body Radiotherapy 
(SABR) for vertebral metastases is an emerging treatment in 
oligometastatic solid tumor patients to achieve long-term 
symptom control and sustain quality of life. Accurate patient 
positioning is essential to avoid radiation-induced 
myelopathy. In absence of a 6D robotic couch system at the 
treatment unit, we assessed the inter- and intrafraction 
setup errors for patients positioned with and without vacuum 
mattress. 
Materials and Methods: From November 2013 until July 2014, 
9 patients with 10 vertebral metastases were treated 
consecutively with fractionated SABR (48Gy/24 fractions on 
the entire affected vertebra with an integrated boost to 
66Gy/24 fractions on the metastasis). A dedicated online 
match with the planning-CT on the spinal canal of the 
involved vertebra was performed using ConeBeam CTs 
(CBCTs) prior to every treatment fraction. CBCTs acquired 
prior to and after treatment were analyzed to respectively 
evaluate the interfraction pitch and roll setup errors and the 
intrafraction motions.  
Results: A total of 411 pre- and post SABR CBCTs were 
evaluated in 5 patients immobilized using a vacuum mattress 
and in 4 patients without immobilization device. 4 thoracic, 4 
lumbar, and 2 sacral vertebral metastases were treated. No 
acute grade ≥ 3 toxicity was observed. For the interfraction 
setup error analysis, 214 pre-treatment CBCTs were matched 
offline with planning-CTs to determine the possible pitch and 
roll. A pitch and roll setup error of ≥ 2° was observed in 35 
fractions (16%). Pitch and roll of ≥ 2° and ≥ 3° were less 
frequent in fractions treated with vs without a vacuum 
mattress: for ≥ 2°: 9% vs 26%, and for ≥ 3°: 2% vs 4%, 
respectively (p=0.04 chi-square test, Figure 1). The mean ± 
SD of absolute interfraction pitch and roll values for patients 
with and without vacuum mattress were 0.90 ± 0.61mm and 
0.90 ± 0.82 mm (non-significant, t-test), respectively.  
For the intrafraction motion analysis, a total of 197 post-
treatment CBCTs were evaluated. Intrafraction errors of ≥ 
2mm and ≥ 2° were less frequent in fractions with vs without 
a vacuum mattress (1% vs 20%, respectively; p<0.001 chi-
square test). Also, intrafraction errors >3mm and >3° were 
less frequent in fractions treated using vacuum mattress (0% 
vs 5%, respectively; p<0.001 chi-square test, Figure 1). The 
mean ± SD of absolute intrafraction motion values for 
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patients with and without immobilization were 0.39 ± 0.34 
mm and 0.71 ± 0.75 mm, respectively (p<0.001, t-test).  
 
 
Conclusions: During spine SABR, large inter- and intrafraction 
motion of ≥ 3mm and/or ≥ 3° is uncommon. The use of a 
vacuum mattress improves the intrafraction setup accuracy in 
particular, but also the interfraction setup accuracy 
regarding setup errors ≥ 2°. A 6D couch positioning correction 
may further increase setup accuracy. 
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Purpose/Objective: The risk of second tumor induced by 
radiotherapy treatments is an issue addressed in long survival 
patients. Prostate radiotherapy represents a critical scenario 
considering the increase of target dose and irradiated volume 
with IMRT approaches and the decrease of mean age of 
patients. The goal of this study was to evaluate the impact of 
modern rotational IMRT techniques in the risk of second 
tumor induction for prostate patients in age classes from 50 
to over 70.  
Materials and Methods: Based on both consolidated models 
(BEIR VII and Shuriak age dependent organ risk coefficients) 
and doses to the critical organs, the Lifetime Attributable 
Risk (LAR) for second tumor induction was calculated 
simulating small field (prostate+seminal vesicles) and large 
field (whole pelvis,WP) for Helical Tomotherapy (HT) and 
Rapid Arc (RA), according to our clinical protocol of moderate 
hypofractionation (71.4Gy in 28 fr) and concomitant 
irradiation of WP to 51.8Gy for intermediate/high risk 
patients. Due to the lack of calculation algorithms in 
Treatment Planning Systems (TPS) where leakage and 
internal radiation scattering are unreliable at large distance 
from target, the doses to the critical organs outside the 
treatment volume were measured with termoluminescent 
dosemeters (TLD) in an anthropomorphic phantom. Whereas, 
doses to the organs closest to the treatment volume, as 
bladder, rectum, colon, bone marrow, were derived from TPS 
data. Doses from IGRT procedures were also assessed based 
on phantom measurements.  
Results: The LAR values for all organs are reported in the 
Table. For small field in the oldest age class the evaluated 
LAR, 2%, agree with literature data confirming the robustness 
of our estimate methods. LAR values increase by a factor of 
approximately 3 as age decreases from 70 to 50s. WP 
irradiation translates in a LAR increase of a factor 2, with 
corresponding absolute values around 10-13% for ages 50-60s. 
No differences were found between RA and HT. Bladder and 
rectum cancer and leukemia represent almost the totality of 
risk for second tumor induction with small fields, whereas, a 
significant risk for colon tumor induction is added in large 
pelvic irradiation with LAR values comparable to bladder. 
IGRT adds a minor, although non-negligible, contribution to 
the risk (0,2-0,6%) if daily set-up verification and high 
resolution modality is included. 
 
 
Conclusions: As prostate cancer is detected earlier the 
probability of an increase in early stage, young patients rises, 
and life expectancy thus increases. Radiotherapy improved 
the tailoring of the dose around the target at the cost of a 
greater dose to surrounding organs, so increasing the risk of 
second tumor induction, especially for patients expected to 
reach a survival of 15 years or more. The increased risk 
induced by lower age and larger volumes should be 
